Gilead Net Income from 2010 to 2024
GILD Stock | USD 73.25 0.24 0.33% |
Net Income | First Reported 1990-06-30 | Previous Quarter 2.2 B | Current Value 1.4 B | Quarterly Volatility 1.3 B |
Check Gilead Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gilead main balance sheet or income statement drivers, such as Interest Expense of 534.5 M, Total Revenue of 28.5 B or Gross Profit of 28.5 B, as well as many exotic indicators such as Short Term Coverage Ratios of 4.23, Price Earnings Ratio of 20.47 or Price To Sales Ratio of 3.54. Gilead financial statements analysis is a perfect complement when working with Gilead Sciences Valuation or Volatility modules.
Gilead | Net Income |
Latest Gilead Sciences' Net Income Growth Pattern
Below is the plot of the Net Income of Gilead Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Gilead Sciences financial statement analysis. It represents the amount of money remaining after all of Gilead Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Gilead Sciences' Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gilead Sciences' overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 5.61 B | 10 Years Trend |
|
Net Income |
Timeline |
Gilead Net Income Regression Statistics
Arithmetic Mean | 5,815,362,304 | |
Coefficient Of Variation | 86.54 | |
Mean Deviation | 3,556,473,438 | |
Median | 4,628,000,000 | |
Standard Deviation | 5,032,563,458 | |
Sample Variance | 25326695T | |
Range | 18.1B | |
R-Value | (0.03) | |
Mean Square Error | 27254460.9T | |
R-Squared | 0.0007 | |
Significance | 0.92 | |
Slope | (30,806,854) | |
Total Sum of Squares | 354573729.5T |
Gilead Net Income History
Other Fundumenentals of Gilead Sciences
About Gilead Sciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Gilead Sciences income statement, its balance sheet, and the statement of cash flows. Gilead Sciences investors use historical funamental indicators, such as Gilead Sciences's Net Income, to determine how well the company is positioned to perform in the future. Although Gilead Sciences investors may use each financial statement separately, they are all related. The changes in Gilead Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Gilead Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Gilead Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Gilead Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for 2024 | ||
Net Income | 5.6 B | 3 B | |
Net Income Applicable To Common Shares | 5.3 B | 4.9 B | |
Net Income From Continuing Ops | 5.8 B | 6.6 B | |
Net Income Per E B T | 0.83 | 0.94 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Gilead Sciences Correlation against competitors. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3 | Earnings Share 4.5 | Revenue Per Share 21.728 | Quarterly Revenue Growth (0.04) |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.